Future Table of Contents


Future Table of Contents

Volume 24, Number 5

Orbital mass as first presentation of metastatic p16+ oropharyngeal squamous cell carcinoma
J. Corbett, D. Wilke, J. Trites, N. Lamond

Training Oncoplastic Breast Surgeons: Where Does Canada Stand?
J. Maxwell, A. Aranaout, R. Hanrahan, M. Brackstone

Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex due to a TSC2 deletion – a case report
M. Niedziela

Neoadjuvant systemic therapy in breast cancer; utilization and radiotherapy practice trends
T.A. Koulis, K. Beecham, C. Speers, S. Tyldesley, D. Voduc, C. Simmons, R. Olson

Short course Lenalidomide plus Low Dose Dexamethasone in Treatment of Newly Diagnosed Multiple Myeloma – Single Center study
W.M. Jose, P. Keechilat, G.S. Trivadi

Conditional survival after diagnosis with malignant brain tumour in Canada: 2000-2008
Y. Yuan, J. Ross, Q. Shi, F. Davis

The Effects of the Community-Based, Wellspring Cancer-Exercise Program on Functional and Psychosocial Outcomes in Cancer Survivors
D. Santa Mina, D. Au, J. Brunet, J. Jones, G. Tomlinson, N. Taback, D. Field, A. Berlingeri, H. Bradley, D. Howell

A case of metastatic prostate cancer and immune thrombocytopenia
D. Betsch, S. Gray, S.E. Zed

The clinical significance of occult gynecologic primary tumours in metastatic cancer
M.B. Hannouf, E. Winquist, S.M. Mahmud, M. Brackstone, S.S. Sarma, G. Rodrigues, P.K. Rogan, J.S. Hoch

Clinical Utility of Multigene Profiling Assays in Early-Stage Breast Cancer
M.C. Chang, L.H. Souter, S. Kamel-Reid, M. Rutherford, P. Bedard, M. Trudeau, J. Hart, A. Eisen

Cost analysis of breast cancer diagnostic assessment programs
G.N. Honein-AbouHaidar, J.S. Hoch, M.J. Dobrow, T. Stuart-McEwan, D.R. McCready, A.R. Gagliardi

Lung cancer care trajectory at a Canadian Centre: an evaluation of wait times effect on clinical outcomes
G. Kasymjanova, D. Small, T.R. Jagoe, G. Batist, W. Sateren, P. Ernst, C. Pepe, L. Sakr, V. Cohen, J. Agulnik

The impact of pCODR on cancer drug funding decisions
A. Srikanthan, H. Mai, N. Penner, E. Amir, A. Laupacis, M. Sabharwal, K. Chan

Development of an online, patient-centered decision aid for patients with oropharyngeal cancer in the transoral robotic surgery era
J.S. Lam, G.M. Scott, D.A. Palma, K. Fung, A.V. Louie

What we learned in kindergarten: 5 tips for collaboration in oncology
A. Arnaout

Shifting practice in definitive chemoradiation for localized esophageal cancer
X.M. Qu, J.J. Biagi, W.M. Hopman, A. Mahmud

Framingham Risk Score underestimates risk of cardiovascular events in HER2+ breast cancer population
W. Law, C. Johnson, M. Rushton, S. Dent

Breast cancer and dermatomyositis: a case study and literature review
E.M. Hendren

A Mighty Khatun
S. Lalani

Staging and Surgical Approaches in Gastric Cancer: A Clinical Practice Guideline
N. Coburn, R. Cosby, L. Klein, G. Knight, R. Malthaner, J. Mamazza, C.D, Mercer, J, Ringash

Coordination of radiological and clinical care reduces wait times to breast cancer diagnosis
E. McKevitt, C. Dingee, R. Warburton, J.-S. Pao, C.J. Brown, C. Wilson, U. Kuusk

The Timeliness of Oncology Drug Review Process for Public Funding in Canada
T. Younis, C. Skedgel

Coming of Age in Canada: A Study of Population-Based Genetic Testing for Breast and Ovarian Cancer
M.R. Akbari, N. Gojska, S.A. Narod

Upcoming in Current Oncology

A systematic review and network meta-analysis of post-imatinib therapy in advanced gastrointestinal stromal tumour
K. Shah

Feasibility of Assessing Patient Health Benefits and Incurred Costs from Early Dysphagia Intervention during and immediately following Chemoradiotherapy for Head and Neck Cancer
R. Martino, J. Ringash, L. Durkin, E. Greco, S. Hui-Huang, W. Xu, C. Longo

Cancer centre follow-up care of breast, colorectal, gynecological, and prostate cancer survivors
R. Urquhart, L. Lethbridge, G.A. Porter

Understanding quality of evidence in survivorship care plans for Breast Cancer patients: should we expect standardized plans across jurisdictions?
V. D'Souza, H. Daudt, A. Kazanjian

Effect of early palliative care on quality of life in patients with non–small-cell lung cancer
H. Zhuang, H. Zhang, L. Wang, Y. Ma

Wait times for diagnosis and treatment of lung cancer: a single centre experience
C. Labbé

Phase I Study of concurrent and consolidation Cisplatin and Docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancer
Tina Wanting Zhang, George B. Rodrigues, Alexander V. Louie, David Palma, A. Rashid Dar, Brian Dingle, Walter Kocha, Michael Sanatani, Brian Yaremko, Edward Yu, Jawaid Younus, Mark D. Vincent

Identifying barriers to accrual in radiation oncology randomized trials
D. Palma

Progressive multifocal leukoencephalopathy after ixazomib-based chemotherapy
C. Sawicki, S. Climans, C. Hsia, A. Fraser

PCV toxicity in Low Grade Gliomas
G. Jutras, K. Bélanger, N. Letarte, J.-P. Adam, D. Roberge, B. Lemieux, E. Lemieux-Blanchard, L. Masucci, C. Ménard, J.-P.l Bahary, R. Moumdjian, F. Berthelet, M. Florescu

Toxicity of Adjuvant High‐Dose Interferon for Melanoma in Ontario: Impact of Pre-Treatment Mental Health Services Use on Early Discontinuation
T.P. Hanna, T. Baetz, J. Xu, Q. Miao, C.C. Earle, Y. Peng, C.M. Booth, T. Petrella, D. McKay, P. Nguyen, H. Langley, E. Eisenhauer

Reasons for no systemic therapy in stage IV NSCLC: comparison of years 2003-2006 vs. 2010-2011
J. Jaeeun K

An evaluation of the physical activity information and support posted on cancer centre websites for breast cancer survivors
C. Sabiston

Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA)
M. Uccello, M. Moschetta, G. Mak, T. Alam, C. Murias Henriquez, H.-T. Arkenau

Family histories in pediatric oncology identify patients at risk of cancer predisposition syndromes
A. Hamilton, E. Smith, J. Hamon, E. Tomiak, M. Bassal, S. Sawyer

The Views of Patients with Brain Cancer on Palliative Care: A Qualitative Study
M.J. Vierhout, M. Daniels, P. Mazzotta, J. Vlahos, W.P. Mason, M. Bernstein

Risk and predictors of suicide in colorectal cancer patients: A SEER analysis
H.H. Samawi, A.A. Shaheen, P.A. Tang, D.Y.C. Heng, W.Y. Cheung, M.M. Vickers

Regional process redesign of lung cancer care: a learning health system pilot project
M. Fung-Kee-Fung, D.E. Maziak, J.R. Pantarotto, J. Smylie, L. Taylor, T. Timlin, T. Cacciotti, P.J. Villeneuve, C. Dennie, C. Bornais, S. Madore, J. Aquino, P. Wheatley-Price, R.S. Ozer, D.J. Stewart

Real world outcomes in patients with ALK+ non-small cell lung cancer treated with crizotinib
K.L. Davis

Strategic planning in an academic radiation medicine program
J.L. Hamilton, S. Foxcroft, E. Moyo, J. Cooke-Lauder, T. Spence, P. Zahedi, A. Bezjak, D. Jaffray, C. Lam, D. Létourneau, M. Milosevic, R. Tsang, R. Wong, F.-F. Liu

Irreversible Tyrosine Kinase Inhibition of EGFR with Afatinib in EGFR mutation-positive Advanced Non-Small Cell Lung Cancer
S. Morin-Ben Abdallah, V. Hirsh

Brain Metastases in Non-Small Cell Lung Cancer: Are tyrosine kinase inhibitors and checkpoint inhibitors now viable options?
S. Morin-Ben Abdallah, A. Wong

Adult chronic myelomonocytic leukemia with trisomy 11: a case report
S.H. Yoo, J. Lim, J.M. Byun, J.H. Park, K.H. Kim, I.S. Choi

Anti-angiogenic therapies in non small cell lung cancer
P.M. Ellis, A. Alshangiti, G. Chandhoke

Towards Improved Goals of Care Documentation in Advanced Cancer: Report on the Development of a Quality Improvement Initiative
I. Harle, S. Karim, W. Raskin, W. Hopman, C. Booth

Improving Pneumococcal Vaccine Uptake in Veterans with Chronic Lymphocytic Leukemia Through a Virtual Clinic
E. Chandler Church, R. Banks, B.M. Wilson, L. Arfons, F. Perez, R.L.P. Jump

The Predictive Impact of Primary Tumour Location in the Treatment of Metastatic Colorectal Cancer: A Canadian Consensus Statemen
S, Karim, A, Abrahao, B, Colwell, S, Berry, J, Biagi

No evidence of excessive cancer screening in female non-carriers from BRCA1/2 mutation-positive families
S. Guedaoura, S. Pelletier, W.D. Foulkes, P. Hamet, J. Simard, N. Wong, Z. El Haffaf, J. Chiquette, M. Dorval

Circulating Tumour DNA in EGFR-mutant NSCLC: A Review
M. Cabanero, M. Tsao

Alberta CancerBRIDGES’ Development of a Care Plan Evaluation Measure
J. Giese-Davis, J. Sisler, L. Zhong, Y. Brandelli, J.L. McCormick, C. Railton, L. Shirt, H. Lau, D. Hao, J. Chobanuk, B. Walley, A.A. Joy, A. Taylor, L. Carlson

Resistance developments to EGFR-TKIs, T790M and Clinical trials
G.M. O'Kane, T.A. Barnes, N.B. Leighl

Systemic Therapy for Recurrent Epithelial Ovarian Cancer: A Clinical Practice Guideline
N. Coakley